期刊文献+

卵巢癌分型及其分子遗传学研究进展 被引量:1

Histological types and molecular genetical progress in ovarian carcinoma
下载PDF
导出
摘要 卵巢癌是最常见的妇科恶性肿瘤之一,如何正确认识这类肿瘤一直备受关注。多年的病理形态学观察和临床病理资料积累,提示其各组织学亚型的生物学行为和发生、发展规律是有差异的。近年分子遗传学技术的应用为更客观的认识、诊断这类肿瘤和进一步指导患者的临床治疗、估价预后提供了新的研究方法和途径。本文对卵巢癌及其不同组织学亚型分子遗传学改变的研究进展进行综述。 Ovarian carcinoma is one of the most common and lethal gynecological malignancy, and the knowledge about its nature has always been concerned. Clincopathological data indicated that different histological subtypes had their own biological features, and were associated with distinct pathogenesis. Recently, technical application of molecular genetics has provided a new approach to histological diagnosis more objectively and further indicating clinical therapy and evaluating patients' prognosis. Here we review molecular genetic progress in each of histological subtypes of ovarian carcinoma.
出处 《生殖医学杂志》 CAS 2006年第2期132-136,共5页 Journal of Reproductive Medicine
关键词 卵巢癌 组织病理 分子遗传 基因 Ovarian carcinoma Histopathology Molecular genetics Gene
  • 相关文献

参考文献3

二级参考文献27

  • 1郭丽娜,连利娟.卵巢浆液性交界瘤高危病例的病理特点[J].生殖医学杂志,2004,13(3):179-181. 被引量:6
  • 2孙爱达 连利娟.子宫内膜异位症.林巧稚妇科肿瘤学(第3版)[M].北京:人民卫生出版社,2000.697-713.
  • 3Trope C, Kern J, Vergate IB, et al. Are borderline tumor of ovary overtreated both surgically and systemically? A review of 4 prospective randomized trials including 253 patients with borderline tumors[J]. Gynecol Oncol, 1993,51(2):236-243.
  • 4Kennedy HW, Hart WR. Ovarian papillary serous tumor of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastases, and transformation to invasive serous carcinoma[J]. Cance
  • 5Morice P, Camatte S, El Hassan J, et al. Clinical outcome and fertility after conservative treatment of ovarian borderline tumors[J]. Fertil Steril, 2001,75(1):92-96.
  • 6Morise RT, Gershenson Dm, Silva EG, et al. Outcome and reproductive function after conservative surgery for borderline ovarian tumors[J]. Obstet Gynecol, 2000,95(4):541-547.
  • 7Camatte S, Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumor of the ovary[J]. Int J Obstet Gynecol, 2002,109(4):376-380.
  • 8Prat J, Nicotolis M. Serous borderlive tumors of the ovary: a long term follow up study of 137 cases, including 18 with a micropapillary pattern and 20 with invasion[J]. Am J Surg Pathol, 2002,26(9):1111-1128.
  • 9Donnez J, Manschke A, Berlier M,et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary[J]. Fertil Steril, 2003,79(5):1216-1221.
  • 10Darai E, Teboul J, Fauconnier A,et al. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy[J]. Acta Obstet Gynecol Scand, 1998,77(4):451-457.

共引文献22

同被引文献14

  • 1郭翠英,张吟真,朱晓研.p16基因表达在卵巢癌分化程度诊断及化疗疗效判断中的意义[J].诊断学理论与实践,2005,4(3):199-201. 被引量:4
  • 2王智峰,张珊珊,刘玉兰,叶颖江,王杉.Wnt1和β-catenin在结直肠腺瘤中的表达及其意义[J].中华普通外科杂志,2007,22(1):21-24. 被引量:3
  • 3Badiglian Filho L, Oshima C T, Deoliveira Lima F, et al. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer[J]. On cology Reports, 2009, 21(2):313-320.
  • 4Rask K, Nilsson A, Brannstrom M, et al. Wnt-signalling path-way in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta[J]. Br J Cancer, 2003, 89(7): 1298-1304.
  • 5Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development[J]. J Cancer Res Clin Oncol, 2003, 129(4) : 199-221.
  • 6Jeays-Ward K, Hoyle C, Brennan J , et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad[J]. Development, 2003,130(16) : 3663- 3670.
  • 7Yao H H, Matzuk M M, Jorgez C J,et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis[J]. Dev Dyn, 2004,230(2) :210-215.
  • 8Ricken A, Lochhead P, Kontogiannea M, et al. Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs [J]. Endocrinology, 2002,143(7): 2741-2749.
  • 9He B, Barg R N, You L, et al. Wnt signaling in stem cells and non small cell lung cancer[J]. Clin Lung Cancer, 2005, 7 (1): 54-60.
  • 10Li Y, Hively W P, Varmus H E. Use of MMTV Wnt-1 transgenie mice for studying the genetic basis of breast cancer[J]. Oncogene, 2000, 19(8):1002-1009.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部